RG 7314

Drug Profile

RG 7314

Alternative Names: RG-7314; RO 5028442; RO-5285119

Latest Information Update: 17 Feb 2017

Price : $50

At a glance

  • Originator Roche
  • Class Antipsychotics; Small molecules
  • Mechanism of Action Vasopressin 1 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Autistic disorder

Most Recent Events

  • 01 Nov 2016 Phase-II clinical trials in Autistic disorder (In children, In adolescents) in USA (PO) (NCT02901431)
  • 12 Sep 2016 Roche plans a phase II trial in Autistic disorder (In children, In adolescents) in USA (NCT02901431)
  • 01 Sep 2016 Hoffmann-La Roche completes a phase II trial in Autistic disorder in USA (PO) (NCT01793441)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top